ABSTRACT. Retinitis pigmentosa (RP) is a retinal degenerative disorder that often causes complete blindness. Mutations of more than 50 genes have been identified as associated with RP, including the CACNA1F gene. In a recent study, by employing next-generation sequencing, we identified a novel mutation in the CACNA1F gene. In this study, we used the amplification refractory mutation system (ARMS) and identified a single nucleotide change c.1555C>T in exon 13 of the CACNA1F gene, leading to the substitution of arginine by tryptophan (p.R519W) in a Chinese individual affected by RP. Establishment and rapid detection of CACNA1F gene by ARMS This study actually confirms this novel mutation, and establishes the ARMS technique for the detection of mutations in RP.
INTRODUCTION
Retinitis pigmentosa (RP; Online Mendelian Inheritance in Man No. 268000) comprises a heterogeneous group of hereditary retinal degenerative disorders that cause progressive loss of photoreceptors, severe vision impairment, night blindness, abnormal color vision, fundus degeneration, and often complete blindness (Hartong et al., 2009; Wu et al., 2014) . RP affects approximately 1 in 4000 people and more than 1 million individuals worldwide (Katagiri et al., 2014) . According to the RetNet database, mutations in more than 50 genes are associated with RP (Wang et al., 2014) . Different mutations in different genes can have similar consequences. However, different mutations in the same gene may cause different diseases/ phenotypes (Yang et al., 2014) .
The CACNA1F gene (Online Mendelian Inheritance in Man No. 300110) encodes a voltage-dependent L-type calcium channel, the Ca v 1.4 channel. It is expressed in both rod and cone terminals mediating neurotransmitter secretion at ribbon synapses of the retinal photoreceptors, and therefore plays an important role in signal transmission from photoreceptors to bipolar cells in the retinal neurons (Baumann et al., 2004; Hauke et al., 2013) . Mutations in the CACNA1F gene are associated with some progressive retinal disorder with a large phenotypic variability . A recent study that used next-generation sequencing reported a missense mutation in the CACNA1F gene associated with RP (Zhou et al., 2015) .
Various molecular techniques have been developed to detect mutations and, until recently, Sanger sequencing was the main method for RP molecular diagnosis. However, it appears that this technique is not ideal for the rapid screening of large numbers of samples, and is expensive in terms of reagents and labor; next-generation sequencing might provide a solution (Fu et al., 2013b) . However, next-generation sequencing is a sophisticated tool and is also expensive. The amplification refractory mutation system (ARMS) may provide a promising alternative for molecular diagnosis because it is rapid, simple, cost-effective, and safe for the detection of known point mutations worldwide (Hassan et al., 2013; Hanafi et al., 2014) . Newton et al. (1989) first described the ARMS technique, which is a polymerase chain reaction (PCR)-based method, and requires only targeted PCR amplification and gel electrophoresis of the amplicon. In this method, an allele-specific oligonucleotide primer with a triple end is used with a common primer in one PCR in which the presence of an amplified mutant detected by agarose gel electrophoresis indicates the presence of the mutation allele. Absence of the amplified mutant suggests the presence of the normal DNA sequence at that specific site. In parallel, a corresponding normal primer is used with a common primer in another PCR in which the presence of a normal amplified product suggests presence of a normal DNA sequence at that specific site, while its absence suggests the presence of the mutant allele (Newton et al., 1989) . In this study, we used the ARMS technique to establish and detect a missense mutation in the CACNA1F gene associated with RP. 
MATERIAL AND METHODS

Clinical diagnosis and sample collection
The Chinese proband suffering from RP in this study has been described previously (Zhou et al., 2015) . Genomic DNA from the proband and his family was isolated from peripheral leukocytes using a previously described method (Fu et al., 2000 (Fu et al., , 2002 Fu, 2012; Zhou et al., 2015) .
Design of ARMS primers
ARMS primers for the M067 family with wild type and mutant were designed at the 5'-end with one base mismatched or two bases mismatched, as shown in Table 1 , according to the heterozygous missense mutation (c.1555C>T, p.R519W) located in exon 13 of the CACNA1F gene (GenBank accession No.: NM_005183, NP_005174) on the human X chromosome (Zhou et al., 2015) . A common primer or ordinary primer was located at the 3'-end of this gene.
ARMS-PCR and agarose gels electrophoresis
The PCR system (10 μL total) comprised: 1 μL 2.5 μM primers, 1 μL DNA template (10 ng), 5 μL 2X PCR Taq Master Mix (TianGen Biotech Co. Ltd., Beijing, China), and 3 μL double-distilled H 2 O. The PCR regimen was as follows: initial denaturation at 95°C for 90 s, followed by 32 cycles of 40 s at 94°C, 30 s at 63°C, 30 s at 72°C, and a final extension of 5 min at 72°C. The PCR amplification was executed in an Applied Biosystems Veriti ® 96-Well Thermal Cycler (Life Technologies, USA) (Fu et al., 2013a) . The amplified PCR products were resolved by electrophoresis on a 1% agarose gel in 1X TAE (Tris-acetate-ethylenediaminetetraacetic acid) buffer at 120 V for 30 min. The agarose gels were then visualized by 0.5 μg/mL ethidium bromide staining, and the images were documented using ChemiDoc XR (Bio-Rad, USA) (Fu, 2012; Fu et al., 2013a) . The DNA marker (DL2000) used in the electrophoresis was purchased from TaKaRa Biotechnology (Dalian) Co. Ltd., China.
Mutation validation
The putative mutations detected by ARMS were validated by Sanger sequencing on an ABI3500 sequencer (Applied Biosystems Inc., Foster City, CA, USA) (Zhou et al., 2015) .
RESULTS
ARMS-PCR results
Wild-type and mutant ARMS primers for the M067 family were designed at the 3'-end with one or two bases mismatched (Table 1) . The primer pair CACNA1F-AP-RC and CACNA1F-AP-LW specific for the wild type was used for detecting the CACNA1F gene allele, the primer pair CACNA1F-AP-RC and CACNA1F-AP-LM was used for detecting the mutant CACNA1F gene c.1555C>T, and the primer pair CACNA1F-AP-RC and CACNA1F-AP-LM2 with two base mismatches was used for enhanced detection of the mutant CACNA1F gene c.1555C>T.
Nucleotides in bold on the primers correspond to the introduced mismatches. The common primer was used as a 3'-end primer. (Figure 1a , lane labeled "2M"), whereas the normal female control and the normal male without mutation showed no amplification ( Figure 1a , lanes labeled ''2M''). The primer pair CACNA1F-AP-RC and CACNA1F-AP-LW specific for the wild type amplified the PCR products in the lane labeled "M" of the patient M067 (Figure 1a) , which indicates that CACNA1F-AP-LW is not specific. Therefore, we designed another primer CACNA1F-AP-LW2 with a mismatch from "T" to "A" at the third position from the 3'-end for detecting the wild-type allele.
Using the primer pair CACNA1F-AP-RC and CACNA1F-AP-LW2, and the primer pair CACNA1F-AP-RC and CACNA1F-AP-LM2, we found that the patient only amplified the mutant allele but did not amplify the wild type allele, whereas the carrier mother M065 and the grandmother M149 amplified both alleles, and normal individuals including M066 and M148 from this family, and the normal "Ctrl1", only amplified the wild-type allele (Figure 2 ). There was no amplification in the "Ctrl2" lane, which did not include a DNA template (Figure 2) . The lane labeled "MK" indicates the DNA molecular weight marker DL2000 with the fragment size (bp). Lanes labeled "2W" indicate ARMS-PCR using primers CACNA1F-AP-RC and CACNA1F-AP-LW2 specific for the wild-type allele with one mismatched base pair. Lanes labeled "W", "M", and "2M" are described in Figure 1 . "Ctrl1" indicates normal control female DNA. "Ctrl2" indicates no DNA template.
Mutation validation of ARMS-PCR
Validation of ARMS-PCR was performed by Sanger sequencing and representative results are shown in Figure 3 (a and b) (Zhou et al., 2015) . The study showed that the proband's grandmother had the same mutation as her grandson, suggesting that the CACNA1F mutation was passed from the grandmother (I:2) to the mother (II:3), leading to the pathogenic mutation in the male offspring, and showed perfect co-segregation with the disease in the family (Zhou et al., 2015) . The father of the proband (II:4) and other members of the family were normal, with the wild-type CACNA1F gene (Zhou et al., 2015) . 
DISCUSSION
Molecular diagnostic techniques are a highly accurate means of helping diagnose a genetic disease. They characterize the spectrum of gene mutations, provide new information about the underlying disease-associated mutation, and may possibly lead to the development of treatments for common inherited disorders (Newton et al., 1989; Fu et al., 2013b) . However, molecular diagnostic techniques have their limitations: they are time-consuming, and prohibitively expensive for laboratories with limited funds (Hassan et al., 2013) . ARMS has proven to be a rapid, simple, and cost-effective technique for screening known mutations (Hanafi et al., 2014) . In our study, we employed ARMS to detect a CACNA1F gene mutation causing RP in a Chinese family.
The CACNA1F gene is located on the X chromosome at p11.23. It encodes a poreforming protein of 1977 amino acids with cytoplasmic amino-and carboxyl-termini separated by four homologous repeat domains (I-IV), each consisting of six transmembrane segments (S1-S6). CACNA1F is expressed preferentially in the inner and outer nuclear layers of the retina, indicative of a specific functional role in visual processing, and mutation in this gene may cause functional abnormality associated with retinal disorders (Naylor et al., 2000) .
Mutations in CACNA1F are mostly associated with incomplete X-linked congenital stationary night blindness type 2A (CSNB2A) (Hauke et al., 2013) . According to the Human Gene Mutation Database, more than 60 different CACNA1F mutations have been reported to cause CSNB2A. A few mutations in the CACNA1F gene have also been reported to be associated with Aland Island eye disease (Jalkanen et al., 2007) , X-linked cone-rod dystrophy (CORDX3) (Jalkanen et al., 2006) , or other retinal disorders Hope et al., 2005) . In 13 families with incomplete CSNB2A, Strom et al. (1998) identified nine different mutations in 10 families, including three nonsense and one frameshift mutation, and indicated that CACNA1F mutations cause a decrease in neurotransmitter release from photoreceptor presynaptic terminals in CSNB2A patients. Jacobi et al. (2003) identified a C deletion at nucleotide 4548 in CACNA1F in two affected members of a French family with CSNB2A, resulting in a frameshift with a predicted premature termination at codon 1524. Jalkanen et al. (2007) identified a novel 425-bp deletion mutation encompassing exon 30 and portions of adjacent introns of the CACNA1F gene, predicted to cause a deletion of the transmembrane domain and consequently an altered membrane topology of the encoded alpha1-subunit of the Ca v 1.4 calcium channel. Jalkanen et al. (2006) identified a deletion/ insertion (IVS28-1 GCGTC-TGG) at the -1 position in the splice acceptor site of intron 28 of the CACNA1F gene in a large Finnish family with CORDX3, resulting in premature termination and exonic deletions of the encoded protein, Ca v 1.4 alpha1 subunit. Vincent et al. (2011) identified a missense mutation in CACNA1F causing CSNB2A and Aland Island eye disease phenotypes in a family, which confirmed that both diseases are allelic in which other genetic or environmental modifiers might influence the expression of CACNA1F.
Here, we have identified a single nucleotide change c.1522C>T in exon 13 of the CACNA1F gene leading to the substitution of arginine by tryptophan (p.R508W) in individuals affected by RP. By employing next-generation sequencing, our recent study identified a mutation at this position in the CACNA1F gene (Zhou et al., 2015) in a Chinese family with RP. Moreover, Zhou et al. (2015) identified the same heterozygous mutation in normal females of this family, indicating that heterozygous females were carriers for RP. This study actually confirms this novel mutation, and establishes the ARMS technique with double-base mismatched primers for the detection of mutations in RP. By using ARMS, 20 different muta-tions of the β-globin gene could be detected effectively in a cost-efficient manner (Hanafi et al., 2014) . Hassan et al. (2013) applied a simple PCR approach involving a multiplex ARMS and one ARMS technique, consisting of 20 β-globin gene mutations, and successfully detected β-thalassemia patients and carriers in Malaysia. Thong et al. (2005) used a two-step molecular diagnostic strategy consisting of the ARMS technique to identify the most common mutations, followed by other DNA-based diagnostic techniques for β-thalassemia alleles, and achieved a 100% success rate in this study. Hanafi et al. (2014) applied a multiplex ARMS technique for the detection of β-globin gene mutations and successfully identified the mutation spectrum in transfusion-dependent β-thalassemia in Malay patients. Interesting, Fu et al. (2000) have performed rapid prenatal gene diagnosis for β-thalassemia by ARMS. However, the ARMS technique is rarely used for RP diagnosis. This study indicates ARMS as a potential molecular tool for mutation detection in RP.
Different mutations of CACNA1F can lead to different phenotypes having a few or more common symptoms, suggesting the need for a thorough clinical examination with visual function tests, together with mutation analysis, for an accurate diagnosis. The ARMS technique is considered an unbiased, time-efficient method, which preferentially allows detection of known mutations in known genes, as in this study. We applied the ARMS technique using double-base mismatched primers and successfully identified the known mutation in the CACNA1F gene.
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